Spain CV, Dayal P, Ding Y, Iribarren C, et al. Usage of Long-Acting Muscarinic Antagonists and Biologics as Add-on Therapy for Patients in the United States with Moderate-to-Severe Asthma. J Asthma 2021 May 10:1-12. doi: 10.1080/02770903.2021.1922915.
PMID: 33970741